Nektar Therapeutics
Open
66.62 -3.62
Overview
Share price change
24h
Min
66.36
Max
69
Income | -8.8M -45M |
|---|---|
Sales | -11M 11M |
EPS | -1.783 |
Profit margin | -413.443 |
Employees | 63 |
EBITDA | -19M -38M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +121.2% upside |
Next Earnings | 6 Aug 2026 |
|---|
Market Cap | -620M 2.3B |
|---|---|
Previous open | 70.24 |
Previous close | 66.62 |
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Nektar Therapeutics Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
12 Months Forecast
Average 153.71 USD 121.2%
High 192 USD
Low 80 USD
Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$